$NAVB Company News
Navidea Biopharmaceuticals falls 8% in premarket 8:51 a.m. Dec. 3, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:55 p.m. Sept. 18, 2012 - MarketWatch
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Navidea Biopharmaceuticals down 32% in premarket 8:47 a.m. Sept. 11, 2012 - Steve Gelsi
Hot stocks to watch 7:32 a.m. Sept. 11, 2012 - MarketWatch.com
Stocks to watch Tuesday: Sonoco, Navidea, Thor 6:58 a.m. Sept. 11, 2012 - MarketWatch
Shuffle Master, Navidea shares drop after hours 5:59 p.m. Sept. 10, 2012 - Carla Mozee
Navidea shares slide 37% in trading after hours 4:29 p.m. Sept. 10, 2012 - Carla Mozee
In focus: Gathering strength 7:23 p.m. July 11, 2012 - Lawrence G. McMillan
Tuesday’s biggest gaining and declining stocks 5:16 p.m. April 3, 2012 - Kate Gibson
Sweet transition for Navidea CEO 7:04 p.m. June 2, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Leadership changes at Navidea 7:29 a.m. May 19, 2014 - Seeking Alpha
We Are Continuing To See Strong Growth In Sales, Says Navidea CFO 2:32 p.m. May 14, 2014 - Seeking Alpha
10-Q: NAVIDEA BIOPHARMACEUTICALS, INC. 2:09 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Navidea Biopharmaceuticals (NAVB) CEO Mark Pykett on Q1 2014 Results - Earnings Call Transcript 1:04 p.m. May 7, 2014 - Seeking Alpha
Navidea Biopharmaceuticals (NAVB) Q1 2014 Results - Earnings Call Webcast 8:25 a.m. May 7, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Navidea Continues To Execute, When Will The Stock Follow? 2:45 a.m. April 9, 2014 - Seeking Alpha
10-K: NAVIDEA BIOPHARMACEUTICALS, INC. 5:02 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Navidea: The Future Of The Company Will Be Borne On The Back Of Lymphoseek 11:17 a.m. March 11, 2014 - Seeking Alpha
Navidea Biopharmaceuticals: 4 Reasons To Buy This $2 Lottery Ticket 11:55 a.m. March 10, 2014 - Seeking Alpha
Navidea Biopharmaceuticals, Inc Management Discusses Q4 2013 Results - Earnings Call Transcript 12:50 p.m. March 6, 2014 - Seeking Alpha
Navidea Biopharmaceuticals Discusses Q4 2013 Results (Webcast) 9:25 a.m. March 6, 2014 - Seeking Alpha
Navidea gets PDUFA date for Lymphoseek sNDA 9:03 a.m. March 5, 2014 - Seeking Alpha
FDA grants priority review for expanded use of Navidea's Lymphoseek 11:28 a.m. Feb. 18, 2014 - Seeking Alpha
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 3:05 p.m. Feb. 7, 2014 - Seeking Alpha
Navidea Biopharma signs first Asian distribution agreement 9:34 a.m. Jan. 7, 2014 - Seeking Alpha
Navidea Biopharmaceuticals Inc. - A Follow Up? 9:02 a.m. Dec. 24, 2013 - Seeking Alpha
Navidea Biopharmaceuticals talks MAA for Lymphoseek, shares slide 2:14 p.m. Dec. 20, 2013 - Seeking Alpha
Navidea Biopharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 29, 2014 - BusinessWire - BZX
Navidea Announces Eleven Scientific Presentations of Results from Lymphoseek® and Manocept™ Studies at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 7:31 a.m. May 20, 2014 - BusinessWire - BZX
Navidea Announces Restructuring of Pipeline Development 4:32 p.m. May 15, 2014 - GlobeNewswire
Technical Data on Biotech Equities -- Research on Navidea Biopharma, MiMedx, Organovo Holdings, and Raptor Pharma 11:10 a.m. May 14, 2014 - PR Newswire - PRF
Navidea Biopharmaceuticals to Announce First Quarter 2014 Financial Results on May 7, 2014 12:25 p.m. April 29, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Provides Progress Updates on Lymphoseek® Programs 5:31 p.m. April 17, 2014 - BusinessWire - BZX
Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by BrokerBank Securities, Inc. 7:00 a.m. April 11, 2014 - PR Newswire - PRF
Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting 7:31 a.m. April 10, 2014 - BusinessWire - BZX
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German Society of Nuclear Medicine Congress 7:31 a.m. March 26, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for Lymphoseek® 5:31 p.m. March 19, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence and Survival Outcomes after Sentinel Lymph Node Biopsy in Patients with Breast Cancer and Melanoma 7:31 a.m. March 14, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC 8:01 a.m. March 6, 2014 - BusinessWire - BZX
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling 8:30 a.m. March 5, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 3:19 p.m. March 3, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Adds New Member to Board of Directors 8:30 a.m. Feb. 19, 2014 - BusinessWire - BZX
Navidea Announces Priority Review for the sNDA to Expand Lymphoseek® Labeling for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer 8:31 a.m. Feb. 18, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces the Presentation of Manocept™ Data at Keystone Symposia for Molecular Cell Biology of Macrophages in Human Disease 8:31 a.m. Feb. 13, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces Positive Initial Results in Single-Center Cohort from Phase 2b Trial of NAV4694 in Subjects with Mild Cognitive Impairment (MCI) 10:16 a.m. Feb. 6, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Present at the 16th Annual BIO CEO and Investor Conference 1:33 p.m. Feb. 4, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Present at 2014 Biotech Showcase(TM) Conference 3:59 p.m. Jan. 7, 2014 - BusinessWire
Navidea Biopharmaceuticals falls 8% in premarket 8:51 a.m. Dec. 3, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:55 p.m. Sept. 18, 2012 - MarketWatch
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Navidea Biopharmaceuticals down 32% in premarket 8:47 a.m. Sept. 11, 2012 - Steve Gelsi
Hot stocks to watch 7:32 a.m. Sept. 11, 2012 - MarketWatch.com
Stocks to watch Tuesday: Sonoco, Navidea, Thor 6:58 a.m. Sept. 11, 2012 - MarketWatch
Shuffle Master, Navidea shares drop after hours 5:59 p.m. Sept. 10, 2012 - Carla Mozee
Navidea shares slide 37% in trading after hours 4:29 p.m. Sept. 10, 2012 - Carla Mozee
In focus: Gathering strength 7:23 p.m. July 11, 2012 - Lawrence G. McMillan
Tuesday’s biggest gaining and declining stocks 5:16 p.m. April 3, 2012 - Kate Gibson
Sweet transition for Navidea CEO 7:04 p.m. June 2, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Leadership changes at Navidea 7:29 a.m. May 19, 2014 - Seeking Alpha
We Are Continuing To See Strong Growth In Sales, Says Navidea CFO 2:32 p.m. May 14, 2014 - Seeking Alpha
10-Q: NAVIDEA BIOPHARMACEUTICALS, INC. 2:09 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Navidea Biopharmaceuticals (NAVB) CEO Mark Pykett on Q1 2014 Results - Earnings Call Transcript 1:04 p.m. May 7, 2014 - Seeking Alpha
Navidea Biopharmaceuticals (NAVB) Q1 2014 Results - Earnings Call Webcast 8:25 a.m. May 7, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. May 6, 2014 - Seeking Alpha
Navidea Continues To Execute, When Will The Stock Follow? 2:45 a.m. April 9, 2014 - Seeking Alpha
10-K: NAVIDEA BIOPHARMACEUTICALS, INC. 5:02 p.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Navidea: The Future Of The Company Will Be Borne On The Back Of Lymphoseek 11:17 a.m. March 11, 2014 - Seeking Alpha
Navidea Biopharmaceuticals: 4 Reasons To Buy This $2 Lottery Ticket 11:55 a.m. March 10, 2014 - Seeking Alpha
Navidea Biopharmaceuticals, Inc Management Discusses Q4 2013 Results - Earnings Call Transcript 12:50 p.m. March 6, 2014 - Seeking Alpha
Navidea Biopharmaceuticals Discusses Q4 2013 Results (Webcast) 9:25 a.m. March 6, 2014 - Seeking Alpha
Navidea gets PDUFA date for Lymphoseek sNDA 9:03 a.m. March 5, 2014 - Seeking Alpha
FDA grants priority review for expanded use of Navidea's Lymphoseek 11:28 a.m. Feb. 18, 2014 - Seeking Alpha
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 3:05 p.m. Feb. 7, 2014 - Seeking Alpha
Navidea Biopharma signs first Asian distribution agreement 9:34 a.m. Jan. 7, 2014 - Seeking Alpha
Navidea Biopharmaceuticals Inc. - A Follow Up? 9:02 a.m. Dec. 24, 2013 - Seeking Alpha
Navidea Biopharmaceuticals talks MAA for Lymphoseek, shares slide 2:14 p.m. Dec. 20, 2013 - Seeking Alpha
Navidea Biopharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 29, 2014 - BusinessWire - BZX
Navidea Announces Eleven Scientific Presentations of Results from Lymphoseek® and Manocept™ Studies at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 7:31 a.m. May 20, 2014 - BusinessWire - BZX
Navidea Announces Restructuring of Pipeline Development 4:32 p.m. May 15, 2014 - GlobeNewswire
Technical Data on Biotech Equities -- Research on Navidea Biopharma, MiMedx, Organovo Holdings, and Raptor Pharma 11:10 a.m. May 14, 2014 - PR Newswire - PRF
Navidea Biopharmaceuticals to Announce First Quarter 2014 Financial Results on May 7, 2014 12:25 p.m. April 29, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Provides Progress Updates on Lymphoseek® Programs 5:31 p.m. April 17, 2014 - BusinessWire - BZX
Navidea Pharmaceuticals Inc. Analyst Report: Long Term Market Potential of Lymphoseek does not Justify Current Valuation by BrokerBank Securities, Inc. 7:00 a.m. April 11, 2014 - PR Newswire - PRF
Navidea Announces Presentation of Study Findings of Manocept™ Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting 7:31 a.m. April 10, 2014 - BusinessWire - BZX
Navidea Announces Presentations Highlighting NAV4694 Beta-Amyloid, PET Imaging Agent at the German Society of Nuclear Medicine Congress 7:31 a.m. March 26, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Provides Update on European Marketing Authorization Application for Lymphoseek® 5:31 p.m. March 19, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Three-Year Recurrence and Survival Outcomes after Sentinel Lymph Node Biopsy in Patients with Breast Cancer and Melanoma 7:31 a.m. March 14, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Closes $30 Million Loan with Oxford Finance, LLC 8:01 a.m. March 6, 2014 - BusinessWire - BZX
Navidea Announces Acceptance for Review of an Additional sNDA to Further Expand Lymphoseek® Labeling 8:30 a.m. March 5, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Announce Fourth Quarter and Full-Year 2013 Financial Results on Thursday, March 6, 2014 3:19 p.m. March 3, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Adds New Member to Board of Directors 8:30 a.m. Feb. 19, 2014 - BusinessWire - BZX
Navidea Announces Priority Review for the sNDA to Expand Lymphoseek® Labeling for Sentinel Lymph Node Detection in Patients with Head and Neck Cancer 8:31 a.m. Feb. 18, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces the Presentation of Manocept™ Data at Keystone Symposia for Molecular Cell Biology of Macrophages in Human Disease 8:31 a.m. Feb. 13, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals Announces Positive Initial Results in Single-Center Cohort from Phase 2b Trial of NAV4694 in Subjects with Mild Cognitive Impairment (MCI) 10:16 a.m. Feb. 6, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Present at the 16th Annual BIO CEO and Investor Conference 1:33 p.m. Feb. 4, 2014 - BusinessWire - BZX
Navidea Biopharmaceuticals to Present at 2014 Biotech Showcase(TM) Conference 3:59 p.m. Jan. 7, 2014 - BusinessWire
